RecruitingNCT04423484
Therapeutic Recommendations for Nephroblastoma
Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.
Sponsor
French Africa Pediatric Oncology Group
Enrollment
1,000 participants
Start Date
Jul 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.
Eligibility
Min Age: 6 MonthsMax Age: 18 Years
Inclusion Criteria1
- Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment.
Exclusion Criteria1
- Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal
Interventions
OTHERData collection
Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04423484